A brand of injectable tirzepatide FDA-approved to treat type 2 diabetes.
Also known as: tirzepatide injection
Mounjaro is a brand of once-weekly injectable tirzepatide approved by the FDA for adults with type 2 diabetes.
It shares its active ingredient with Zepbound, which is approved for weight management.